The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

• Main Authors: Trevor A. Stump, PharmD, BCPP (Author), Leigh Anne Nelson, PharmD, BCPP (Author), Yifei Liu, BS Pharm, PhD (Author), Carrie R. Kriz, MS (Author), Courtney A. Iuppa, PharmD, BCPP (Author), Lauren A. Diefenderfer, PharmD, BCPP (Author), Shelby E. Lang, PharmD, BCPP (Author), Ellie S. R. Elliot, PharmD, BCPP (Author), Roger W. Sommi, PharmD, BCPP, FCCP (Author)
• Format: Book
• Published: American Association of Psychiatric Pharmacists, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice. Methods: A retrospective cha...